Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

ABSTRACT: The purpose of this study is to determine the maximum tolerated dose (MTD) of the combination of OSI-906 and everolimus for the treatment of patients with refractory metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2091466 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR